HomeXTLB • TLV
add
X T L Biopharmaceuticals Ltd
Previous close
ILA 3.00
Day range
ILA 2.70 - ILA 2.90
Year range
ILA 2.10 - ILA 11.80
Market cap
26.46M ILS
Avg Volume
8.57M
P/E ratio
-
Dividend yield
-
Primary exchange
TLV
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Revenue | 258.50K | — |
Operating expense | 1.08M | 156.06% |
Net income | -2.75M | -290.62% |
Net profit margin | -1.06K | — |
Earnings per share | — | — |
EBITDA | -2.16M | — |
Effective tax rate | 3.83% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 259.00K | -83.67% |
Total assets | 714.00K | -70.23% |
Total liabilities | 761.00K | 361.21% |
Total equity | -47.00K | — |
Shares outstanding | 881.39M | — |
Price to book | ∞ | — |
Return on assets | -772.58% | — |
Return on capital | -14,144.24% | — |
Cash Flow
Net change in cash
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Net income | -2.75M | -290.62% |
Cash from operations | — | — |
Cash from investing | — | — |
Cash from financing | — | — |
Net change in cash | — | — |
Free cash flow | — | — |
About
Founded
1993
Headquarters
Website
Employees
10
